Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
112.65
+3.09 (2.82%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 17 analysts that cover Abbott Laboratories stock have a consensus rating of "Strong Buy" and an average price target of $140.24, which forecasts a 24.49% increase in the stock price over the next year. The lowest target is $125 and the highest is $150.
Price Target: $140.24 (+24.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 7 |
| Buy | 7 | 7 | 7 | 8 | 8 | 8 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 18 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $169 → $142 | Buy | Maintains | $169 → $142 | +26.05% | Feb 2, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $155 → $140 | Strong Buy | Maintains | $155 → $140 | +24.28% | Jan 23, 2026 |
| Bernstein | Bernstein | Buy Maintains $154 → $125 | Buy | Maintains | $154 → $125 | +10.96% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $147 → $135 | Buy | Maintains | $147 → $135 | +19.84% | Jan 23, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $140 → $132 | Buy | Maintains | $140 → $132 | +17.18% | Jan 23, 2026 |
Financial Forecast
Revenue This Year
48.28B
from 44.33B
Increased by 8.92%
Revenue Next Year
51.85B
from 48.28B
Increased by 7.39%
EPS This Year
5.74
from 3.72
Increased by 54.41%
EPS Next Year
6.32
from 5.74
Increased by 9.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 50.7B | 54.6B | |||
| Avg | 48.3B | 51.9B | |||
| Low | 46.4B | 49.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.3% | 13.2% | |||
| Avg | 8.9% | 7.4% | |||
| Low | 4.6% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.06 | 6.70 | |||
| Avg | 5.74 | 6.32 | |||
| Low | 5.52 | 5.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 62.9% | 16.6% | |||
| Avg | 54.4% | 10.0% | |||
| Low | 48.3% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.